MetriSense Information

Metabolic syndrome affects over a billion people worldwide, and most of them find out too late. MetriSense is building point-of-care diagnostics that catch metabolic risk while it's still reversible. Our multiplexed lateral flow platform brings lab-grade precision to the exam room, no blood draw sent off to a lab, no week-long wait for results. Born out of research at Tec de Monterrey, MetriSense sits at the intersection of deep science and real-world urgency: metabolic disease is rising fastest exactly where diagnostic infrastructure is weakest. We're closing that gap: one test, one clinic, one patient at a time.